Search

for
Search:

GlossaryBotox (BTX-A)

neurotoxin that temporarily paralyzes muscles to reduce wrinkles

Botox, also known as Botulinum Neurotoxin Type A, is a neurotoxic protein produced by the bacterium Clostridium botulinum. It is commonly used in both medical and cosmetic procedures to temporarily paralyze muscles, thereby reducing the appearance of wrinkles and treating conditions such as chronic migraines, muscle spasms, and excessive sweating.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 55 results

research Extra Facial Aesthetic Indications of Botulinum Toxin: A Review

March 2024 in “Cosmoderma”

Botulinum toxin is used for neck, shoulder, calf, and ankle slimming, and hair loss treatment, but can cause muscle weakness and atrophy with regular use.

research Botulinum Toxin A in the Treatment of Facial Reflex Sympathetic Dystrophy: A Case Report

May 2013 in “Toxicon”

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

research Aesthetic Treatment With Botulinum Toxin: Approaches Specific to Men

8 citations, October 2017 in “Dermatologic Surgery”

Men need higher doses and tailored injection techniques for botulinum toxin treatments due to their unique facial features.

research The Effects of Botulinum Toxin A on Wound and Skin Graft Contraction

17 citations, August 2014 in “Journal of Craniofacial Surgery”

Botulinum toxin-A reduces wound and skin graft contraction.

research The Effect of Intradermal Botulinum Toxin on Androgenetic Alopecia and Its Possible Mechanism

15 citations, April 2020 in “Journal of The American Academy of Dermatology”

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.

View more "btx-a" in research →

Community Join

1 / 1 results

community The Effect of Intradermal Botox on Androgenetic Alopecia and Its Possible Mechanism (Journal of the American Academy of Dermatology (2020)

in Treatment 12 upvotes 4 years ago

Intradermal botulinum toxin (BTX) injections effectively treat androgenetic alopecia (AGA) by inhibiting TGF-β1 secretion from hair follicles. Further research and long-term follow-up are needed to confirm these findings.